Juan Luis Steegmann
- Hematology top 0.5%
- Genetics top 0.5%
- Rheumatology top 1%
- Oncology top 10%
- Public Health, Environmental and Occupational Health top 10%
- Co-authors
- Rüdiger HehlmannHanneke C. Kluin‐NelemansMarkus PfirrmannJoerg HasfordN. C. AllanG. AlimenaMichele BaccaraniHassan Ansari
- Topics
- Chronic Myeloid Leukemia Treatments (63 papers)Chronic Lymphocytic Leukemia Research (49 papers)Eosinophilic Disorders and Syndromes (21 papers)
- Cited by
- HematologyGeneticsRheumatology
- Partner nations
- SpainUnited StatesItaly
In The Last Decade
Juan Luis Steegmann
71 papers receiving 2.2k citations
Hit Papers
Peers
Comparison fields: 5 of 82
- Hematology 1.9k
- Genetics 1.6k
- Rheumatology 929
- Oncology 329
- Public Health, Environmental and Occupational Health 220
Countries citing papers authored by Juan Luis Steegmann
This map shows the geographic impact of Juan Luis Steegmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juan Luis Steegmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juan Luis Steegmann more than expected).
Fields of papers citing papers by Juan Luis Steegmann
This network shows the impact of papers produced by Juan Luis Steegmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juan Luis Steegmann. The network helps show where Juan Luis Steegmann may publish in the future.
Co-authorship network of co-authors of Juan Luis Steegmann
This figure shows the co-authorship network connecting the top 25 collaborators of Juan Luis Steegmann. A scholar is included among the top collaborators of Juan Luis Steegmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juan Luis Steegmann. Juan Luis Steegmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 17 | |
| 3 | 37 | |
| 4 | 18 | |
| 5 | 33 | |
| 6 | 4 | |
| 7 | 7 | |
| 8 | 26 | |
| 9 | 26 | |
| 10 | 229 | |
| 11 | 15 | |
| 12 | 5 | |
| 13 | 3 | |
| 14 | 34 | |
| 15 | The impact of the combination of baseline risk group and cytogenetic response on the survival of patients with chronic myeloid leukemia treated with interferon alpha. | 10 |
| 16 | 35 | |
| 17 | 1 | |
| 18 | 11 | |
| 19 | 22 | |
| 20 | A New Prognostic Score for Survival of Patients With Chronic Myeloid Leukemia Treated With Interferon Alfa Writing Committee for the Collaborative CML Prognostic Factors Project Groupbreakdown → | 518 |
About Juan Luis Steegmann
Juan Luis Steegmann is a scholar working on Hematology, Genetics and Rheumatology, having authored 73 papers that have together received 2.3k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (63 papers), Chronic Lymphocytic Leukemia Research (49 papers) and Eosinophilic Disorders and Syndromes (21 papers). The work is most often cited by research in Hematology (1.9k citations), Genetics (1.6k citations) and Rheumatology (929 citations). Juan Luis Steegmann has collaborated with scholars based in Spain, United States and Italy. Frequent co-authors include Rüdiger Hehlmann, Hanneke C. Kluin‐Nelemans, Markus Pfirrmann, Joerg Hasford, N. C. Allan, G. Alimena, Michele Baccarani, Hassan Ansari, Andreas Hochhaus and Giuseppe Saglio. Their work appears in journals such as Journal of Clinical Oncology, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.